GlassScriptPhysician profile
Jacqueline Muller
NPI 1558337485
$19,641.12
in general payments reported to CMS, 2019-2025
21 companies · $5,545 in 2025
The $5,545 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,621 · 2020: $2,962 · 2021: $2,844 · 2022: $1,794 · 2023: $2,093 · 2024: $2,782 · 2025: $5,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,746 · Long Term Medical Supply Or Device Loan: $2,556 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,745.75 |
| Long Term Medical Supply Or Device Loan | $2,556.00 |
| Education | $117.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $4,350.23 | 2022-2025 | Scoutpro Osmolarity System, Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $2,451.36 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $2,074.45 | 2019-2023 | Flarex |
| Sun Pharmaceutical Industries INC. | $2,038.56 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $1,624.13 | 2022-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $1,026.80 | 2019-2023 | |
| Alcon Vision LLC | $938.03 | 2019-2025 | Simbrinza, Eysuvis, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $868.09 | 2019-2021 | |
| Allergan, INC. | $803.55 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $698.80 | 2024-2025 | Xdemvy |
| Abbvie INC. | $539.28 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $397.06 | 2021-2025 | Acthar |
| Harrow Eye, LLC | $370.43 | 2024-2025 | Vevye |
| Dompe US, INC. | $370.37 | 2021-2025 | Oxervate |
| Tearlab Corp | $369.30 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $274.52 | 2019-2025 | Lipiflow System Activator (Disposable) |
| Shire North American Group INC | $264.66 | 2019 | |
| Sight Sciences, INC. | $109.76 | 2022-2023 | Tearcare System |
| Akorn Operating Company LLC | $35.07 | 2021 | |
| Mallinckrodt Enterprises LLC | $26.47 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $10.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Muller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.